Biotronik (Berlin) reported that it will commence with the launch of its next generation unique technology platform Ilesto DX. The device is part of its Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices), which recently received approval.

Crosstrees Medical (Boulder, Colorado) reported that it has received 510(k) clearance from the FDA for the Crosstrees PVA Pod System for Percutaneous Vertebral Augmentation (PVA).

To say that Neuros Medical (Cleveland) has been busy as of late would be an understatement. The firm is focused on raising money for a Series B funding round; just received an Investigational Device Exemption for its Altius product, which delivers high frequency electrical nerve block technology for patients suffering from chronic pain; and released results of a pilot study on the device.